0:00
/
Generate transcript
A transcript unlocks clips, previews, and editing.

Why Are Meningitis Cases Falling While Young People Are Still Dying?

The uncomfortable possibility is that we are not seeing less danger. We may be seeing disease present differently.

I am concerned about population immunity since the Covid pandemic.

This is not said lightly. I am not suggesting that every infection now behaves in a new way, or that every outbreak has one simple explanation. But when I look at the recent meningitis cases in the UK, something does not sit right.

It is not that young people cannot get meningitis. They can. It has always been a serious and sometimes fatal disease. What troubles me is the pattern. We have seen a major outbreak in Canterbury, where two young people tragically died, and then further cases in the Reading region, including another young person who lost his life.

Yet when I look at the hospital admission data, meningococcal disease appears to be down. That is the contradiction.

If the numbers are falling, why do these recent events feel so severe? Why are young people deteriorating so quickly? Why does the public story not match the clinical concern?

That is where we need to ask harder questions.

The Sepsis Pattern Came First

Before I looked closely at meningitis, I had been analysing sepsis.

That work started with a simple observation. Recorded sepsis admissions appear to be down, yet several consequences of severe infection are rising. Low blood pressure. Kidney injury. Respiratory failure. Pneumonia. Cardiovascular complications. These are not trivial findings.

If sepsis is truly falling, the downstream complications of severe infection should fall with it. That is not what I was seeing.

So I began to consider another possibility. Perhaps sepsis is not falling in the way the numbers suggest. Perhaps it is being recognised differently, coded differently, or presenting later. Perhaps the immune response itself has changed, so that the early warning signs are less obvious and the collapse comes later but harder.

That same question now applies to meningitis.

Meningococcus Can Be Carried Silently

To understand this, we need to separate carriage from disease.

Many people carry meningococcus in the back of the nose and throat without becoming ill. Roughly one in ten may carry it at any given time, and in young adults that figure can be higher. They may feel perfectly well and have no symptoms, yet still pass the bacteria to others through close contact.

That is the first important point. Meningococcal disease does not require every infected person to be sick. Most carriers are not. The danger comes when the bacteria move from the throat into the bloodstream, or into the lining around the brain and spinal cord. That is when meningococcal septicaemia or meningitis develops.

So when we see an outbreak, the visible cases are only the tip of the iceberg. Beneath them may be a much larger network of silent carriage.

But carriage alone does not explain death. The more important question is why one young person carries the bacteria without symptoms, while another collapses with sepsis or meningitis.

Why Does One Person Become Severely Ill?

This is where host vulnerability matters.

A young person may be exposed to meningococcus and remain well because their immune system clears it, contains it, or stops it crossing the mucosal barrier. Another may be exposed to the same organism, but if their immune system is temporarily weakened or imbalanced, the bacteria break through.

That difference may come down to genetics, recent illness, sleep deprivation, stress, immune status, exposure intensity, and the specific strain.

But in the post-pandemic period, there is one factor I think we are not taking seriously enough: recent or repeated COVID infection.

I have argued for some time that COVID should not be viewed only as an acute respiratory infection. It can disrupt the immune system. It can affect lymphocytes. It can leave people in a state where their immune response is not simply weak, but imbalanced.

That distinction matters. A weak immune system may fail to detect danger early. An imbalanced one may then overreact once the danger becomes established. That is the type of pattern that leads to severe sepsis.

The Immune Team May Be Out of Balance

I often describe the immune system as a team.

The innate system is the frontline response. Monocytes, macrophages, neutrophils and mast cells are the first responders. They move quickly, detect danger, release inflammatory signals, and attack.

The adaptive system is more precise. T cells and B cells coordinate, regulate and remember. Regulatory T cells matter most here, because they apply the brakes that stop the response from running out of control.

One of the striking features of severe COVID is lymphopenia. The lymphocytes fall, and the worse this is, the more severe the disease tends to be. That has always stood out to me.

If someone has recently had COVID and their lymphocyte function is impaired, the frontline responders may remain active while the coordinating and braking system is weakened. Then, if that person meets another infection such as meningococcus, the early response is poorly coordinated. They may not show the expected warning signs in time. And once the bacteria enter the bloodstream, the macrophage-driven inflammatory response can become excessive.

That is how you get leaky blood vessels, low blood pressure, clotting, poor oxygen delivery, kidney injury, and rapid collapse.

That is sepsis. And in meningococcal disease, that is often what kills.

Lower Numbers Do Not Necessarily Mean Lower Risk

This is the core issue. If meningococcal admissions are down, people assume the risk is lower. That may be true at the level of total national incidence. It does not mean the danger has disappeared.

It may mean fewer people are crossing the threshold into coded hospital admissions. It may mean vaccination and reduced transmission have lowered overall numbers. It may mean some disease is being classified differently. It may mean local outbreaks still occur while national numbers stay low.

Most importantly, it may mean that the cases which do emerge are presenting later, and more severely.

That is the pattern I am worried about. Not more meningitis everywhere. Not a national surge. But a possible change in the relationship between exposure, immune response, recognition and outcome.

If a young person is exposed to meningococcus after a recent viral illness, with depleted or dysregulated immune function, the disease may not behave the way we expect. It may not declare itself clearly at the start. It may look like a sore throat, a viral illness, a headache, fatigue or flu.

Then suddenly it becomes sepsis.

Sepsis Dashboard Here >


The Sore Throat Matters

This is why I pay attention when an early symptom is a sore throat.

A sore throat does not prove meningitis. It does not prove COVID or viral co-infection. But it tells me the upper airway may have been involved early.

Meningococcus lives in the nose and throat. COVID and other respiratory viruses affect the same region. The mucosal surface is the boundary between harmless carriage and invasive disease. If that boundary is inflamed, damaged or immunologically altered, the risk changes.

This does not mean every sore throat is dangerous. It means that in the context of a known outbreak, recent viral illness, and rapid deterioration, we should not dismiss early upper-airway symptoms as irrelevant.

They may be part of the sequence.

What I Think May Be Happening

My working hypothesis is this.

COVID continues to circulate. Young people continue to be infected and reinfected. In some, this produces a temporary depletion or dysfunction of lymphocytes, impairing immune coordination and weakening the regulatory control that normally keeps macrophage activation in check.

If that person is then exposed to meningococcus, especially in a high-density social setting, they may be less able to control the bacteria early. Once invasive disease begins, the inflammatory response can become severe very quickly.

This would not necessarily raise national meningitis admissions. But it could raise the probability that a vulnerable individual progresses rapidly to severe sepsis or death after exposure.

That is the pattern I want investigated.

We Need Better Questions

The answer cannot simply be, “meningitis happens.”

Of course it happens. That is not the point.

The point is that we are seeing outbreaks and deaths in young people while the admission numbers suggest a fall. We are also seeing sepsis numbers fall while several severe infection-related complications rise. These patterns deserve serious scientific attention.

If public health decides broader vaccination is needed, the public deserves a clear explanation of why the risk profile has changed. If the answer is strain dynamics, say so. If it is carriage patterns, show the data. If it involves immune vulnerability after repeated viral infections, investigate it properly.

What we cannot do is pretend the pattern does not require explanation.

The Broader Implication

I keep coming back to the same principle.

Post-pandemic disease may not always appear as more of the same diagnosis. Sometimes it appears as altered presentation, delayed recognition, worse outcomes, or unusual clustering in groups we expect to be resilient.

That is why I analyse patterns. Not one headline. Not one case. Not one code. Patterns.

Meningitis may be one of those places where the old assumptions are no longer enough. The bacteria may be the same. The route of spread may be familiar. But the host response may have changed.

If that is true, then the real question is not only how many cases we are counting.

It is whether we are recognising danger early enough in a population whose immune response may no longer behave the way we expect.

Vejon COVID-19 Review is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Discussion about this video

User's avatar

Ready for more?